JP2019500320A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019500320A5 JP2019500320A5 JP2018522569A JP2018522569A JP2019500320A5 JP 2019500320 A5 JP2019500320 A5 JP 2019500320A5 JP 2018522569 A JP2018522569 A JP 2018522569A JP 2018522569 A JP2018522569 A JP 2018522569A JP 2019500320 A5 JP2019500320 A5 JP 2019500320A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- rsv
- protein
- virus
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023065428A JP2023100654A (ja) | 2015-10-29 | 2023-04-13 | キメラｒｓｖ、免疫原性組成物、及び使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562247962P | 2015-10-29 | 2015-10-29 | |
| US62/247,962 | 2015-10-29 | ||
| US201662334547P | 2016-05-11 | 2016-05-11 | |
| US62/334,547 | 2016-05-11 | ||
| PCT/US2016/058976 WO2017075125A1 (en) | 2015-10-29 | 2016-10-27 | Chimeric RSV, Immunogenic Compositions, and Methods of Use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023065428A Division JP2023100654A (ja) | 2015-10-29 | 2023-04-13 | キメラｒｓｖ、免疫原性組成物、及び使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019500320A JP2019500320A (ja) | 2019-01-10 |
| JP2019500320A5 true JP2019500320A5 (enExample) | 2019-12-05 |
| JP7311872B2 JP7311872B2 (ja) | 2023-07-20 |
Family
ID=58630734
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018522569A Active JP7311872B2 (ja) | 2015-10-29 | 2016-10-27 | キメラｒｓｖ、免疫原性組成物、及び使用方法 |
| JP2023065428A Pending JP2023100654A (ja) | 2015-10-29 | 2023-04-13 | キメラｒｓｖ、免疫原性組成物、及び使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023065428A Pending JP2023100654A (ja) | 2015-10-29 | 2023-04-13 | キメラｒｓｖ、免疫原性組成物、及び使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11235050B2 (enExample) |
| EP (1) | EP3368547A4 (enExample) |
| JP (2) | JP7311872B2 (enExample) |
| KR (1) | KR20180085730A (enExample) |
| CN (1) | CN108602858A (enExample) |
| BR (1) | BR112018008708A2 (enExample) |
| CA (1) | CA3003726A1 (enExample) |
| MX (1) | MX2018005462A (enExample) |
| SG (1) | SG11201803581VA (enExample) |
| WO (1) | WO2017075125A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105189756B (zh) | 2013-03-14 | 2021-06-11 | 爱默蕾大学 | 具有沉默突变的重组rsv、其相关疫苗和方法 |
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| MX2018012094A (es) | 2016-04-05 | 2019-01-10 | Janssen Vaccines & Prevention Bv | Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas. |
| EP3606942B1 (en) | 2017-04-04 | 2025-06-11 | University of Washington | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use |
| CN112088014B (zh) | 2018-02-28 | 2026-03-24 | 华盛顿大学 | 自组装纳米结构疫苗 |
| PE20211469A1 (es) * | 2018-11-13 | 2021-08-05 | Janssen Vaccines And Prevention B V | Proteinas f de prefusion del vrs estabilizadas |
| EP3923983A4 (en) | 2019-02-11 | 2023-02-22 | Emory University | CHIMERIC RSV AND HMPV F PROTEINS, IMMUNOGENIC COMPOSITIONS AND METHODS OF USE |
| US20230355737A1 (en) * | 2020-09-28 | 2023-11-09 | Dbv Technologies | Particle comprising an rsv-f protein for use in rsv vaccination |
| AU2022254738A1 (en) * | 2021-04-08 | 2023-09-07 | Codagenix Inc. | Method of eliciting an immune response against respiratory syncytial virus |
| US12304929B2 (en) * | 2021-04-12 | 2025-05-20 | Sk Bioscience Co., Ltd. | Recombinant RSV live vaccine strain and the preparing method thereof |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5583024A (en) | 1985-12-02 | 1996-12-10 | The Regents Of The University Of California | Recombinant expression of Coleoptera luciferase |
| IL105456A (en) | 1992-04-21 | 1996-12-05 | American Home Prod | Vaccines of attenuated respiratory syncytial virus |
| AT401526B (de) | 1993-02-10 | 1996-09-25 | Scheirer Winfried | Reagenzlösung zur stabilisierung der lumineszenz bei der luciferasemessung |
| DK0702085T4 (da) | 1994-07-18 | 2010-04-06 | Conzelmann Karl Klaus Prof Dr | Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus |
| US7465574B2 (en) | 1994-09-30 | 2008-12-16 | Medimmune, Llc | Recombinant RSV virus expression systems and vaccines |
| US6689367B1 (en) | 1995-09-27 | 2004-02-10 | The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| US7485440B2 (en) | 1995-09-27 | 2009-02-03 | The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
| US6923971B2 (en) | 1995-09-27 | 2005-08-02 | The United States Of America As Represented By The Department Of Health & Human Services | Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes |
| US6713066B1 (en) | 1996-07-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
| US7846455B2 (en) | 1996-07-15 | 2010-12-07 | The United States Of America As Represented By The Department Of Health And Human Services | Attenuated chimeric respiratory syncytial virus |
| US6264957B1 (en) | 1995-09-27 | 2001-07-24 | The United States Of America As Represented By The Department Of Health And Human Services | Product of infectious respiratory syncytial virus from cloned nucleotide sequences |
| US6214805B1 (en) | 1996-02-15 | 2001-04-10 | The United States Of America As Represented By The Department Of Health And Human Services | RNase L activators and antisense oligonucleotides effective to treat RSV infections |
| US6699476B1 (en) | 1996-07-15 | 2004-03-02 | Peter L. Collins | Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| EP0912724B1 (en) | 1996-07-15 | 2009-12-09 | The Government of The United States of America, as represented by The Department of Health and Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| US5976796A (en) | 1996-10-04 | 1999-11-02 | Loma Linda University | Construction and expression of renilla luciferase and green fluorescent protein fusion genes |
| US6074859A (en) | 1997-07-08 | 2000-06-13 | Kikkoman Corporation | Mutant-type bioluminescent protein, and process for producing the mutant-type bioluminescent protein |
| US20040005542A1 (en) | 2001-06-22 | 2004-01-08 | Krempl Christine D | Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes |
| US20020018780A1 (en) * | 2000-05-25 | 2002-02-14 | Scott Koenig | Epitope-based vaccine for respiratory syncytial virus F-protein |
| WO2004087062A2 (en) | 2003-03-28 | 2004-10-14 | Medimmune Vaccines, Inc. | Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| NZ548107A (en) | 2003-12-24 | 2009-09-25 | Nederlanden Staat | A respiratory syncytial virus with a genomic deficiency complemented in trans |
| EP2808384B1 (en) | 2004-10-08 | 2017-12-06 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Modulation of replicative fitness by using less frequently used synonymous codons |
| US7951384B2 (en) | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
| WO2008133663A2 (en) | 2006-11-30 | 2008-11-06 | Government Of The United States Of America, As Represented By The Secretary, | Codon modified immunogenic compositions and methods of use |
| PL2139515T5 (pl) | 2007-03-30 | 2024-04-08 | The Research Foundation Of The State University Of New York | Atenuowane wirusy przydatne w szczepionkach |
| US8580270B2 (en) | 2008-09-30 | 2013-11-12 | University Of Massachusetts | Respiratory synctial virus (RSV) sequences for protein expression and vaccines |
| BRPI0921424A2 (pt) | 2008-11-05 | 2016-01-05 | Merck Sharp & Dohme | vírus sincicial respiratório atenuado, composição imunogênica, molécula de ácido nucléico, célula recombinante, método para produzir uma resposta imune protetiva em um paciente, e, uso de uma quantidade imunologicamente eficaz de um ou mais dos seguintes: um rsv atenuado, uma população de rsv atenuado e uma composição imunogênica. |
| ES2987238T3 (es) | 2008-12-09 | 2024-11-14 | Novavax Inc | Proteínas F del RSV modificadas y métodos de su uso |
| EP4183412B1 (en) | 2009-07-15 | 2024-08-14 | GlaxoSmithKline Biologicals SA | Rsv f protein compositions and methods for making same |
| WO2011046925A1 (en) | 2009-10-12 | 2011-04-21 | Technovax, Inc. | Respiratory syncytial virus (rsv) virus-like particles (vlps) |
| US10227569B2 (en) | 2011-04-12 | 2019-03-12 | Emory University | Respiratory syncytial virus expression vectors |
| RS56748B1 (sr) * | 2011-05-13 | 2018-03-30 | Glaxosmithkline Biologicals Sa | Pre-fuzioni rsv f antigeni |
| CA2840982C (en) | 2011-07-06 | 2022-06-07 | Vira BITKO | Human respiratory syncytial virus vaccine |
| US8816081B2 (en) | 2012-08-06 | 2014-08-26 | Basf Se | Boron containing perylene monoimides, a process for their production, their use as building blocks for the production of perylene monoimide derivatives, monoimide derivatives and their use in dye-sensitized solar cells |
| CA2900713A1 (en) | 2013-02-08 | 2014-08-14 | Steffen Mueller | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization |
| US9738689B2 (en) * | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
| EP4421177A3 (en) | 2013-03-13 | 2024-12-18 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Prefusion rsv f proteins and their use |
| CN105189756B (zh) | 2013-03-14 | 2021-06-11 | 爱默蕾大学 | 具有沉默突变的重组rsv、其相关疫苗和方法 |
| US9060975B2 (en) * | 2013-03-14 | 2015-06-23 | Mucosis Bv | Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions |
-
2016
- 2016-10-27 SG SG11201803581VA patent/SG11201803581VA/en unknown
- 2016-10-27 KR KR1020187014777A patent/KR20180085730A/ko not_active Ceased
- 2016-10-27 JP JP2018522569A patent/JP7311872B2/ja active Active
- 2016-10-27 CA CA3003726A patent/CA3003726A1/en active Pending
- 2016-10-27 EP EP16860742.2A patent/EP3368547A4/en not_active Withdrawn
- 2016-10-27 CN CN201680072681.XA patent/CN108602858A/zh active Pending
- 2016-10-27 US US15/772,275 patent/US11235050B2/en active Active
- 2016-10-27 MX MX2018005462A patent/MX2018005462A/es unknown
- 2016-10-27 BR BR112018008708-4A patent/BR112018008708A2/en not_active Application Discontinuation
- 2016-10-27 WO PCT/US2016/058976 patent/WO2017075125A1/en not_active Ceased
-
2022
- 2022-01-14 US US17/575,829 patent/US12257296B2/en active Active
-
2023
- 2023-04-13 JP JP2023065428A patent/JP2023100654A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11389523B2 (en) | Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein | |
| Lee et al. | Mechanisms of cross-protection by influenza virus M2-based vaccines | |
| JP6990814B2 (ja) | アヒル腸炎ウイルス及びその使用 | |
| JP2017503482A5 (enExample) | ||
| HRP20171213T1 (hr) | Glikoproteinske čestice nalik virusu (vlp) bjesnoće | |
| CN108368488B (zh) | 鸭肠炎病毒及其用途 | |
| CN104353070B (zh) | 一种鸡传染性支气管炎病毒的基因工程亚单位疫苗及其制备方法 | |
| CN104293741A (zh) | 一种呼吸道合胞病毒病毒样颗粒疫苗及其制备方法和应用 | |
| US20230310581A1 (en) | A live attenuated measles virus vectored vaccine for sars-cov-2 | |
| JP2021500876A (ja) | 複数の異種抗原をコードする組換え非病原性マレック病ウイルス構築物 | |
| WO2020215350A1 (zh) | 禽流感与禽腺病毒4型二联基因工程亚单位疫苗及其制备方法 | |
| ZA200509187B (en) | DNA vaccine expressing HA 1 of equine-2 influenza virus | |
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| CN104031889A (zh) | 表达传染性法氏囊病毒vp2蛋白的重组火鸡疱疹病毒疫苗及应用 | |
| Ying et al. | Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle | |
| JP2016513471A (ja) | サイレント変異を有する組換えｒｓｖ、ワクチン、およびそれに関連する方法 | |
| WO2005054451A1 (ja) | 高度安全性痘瘡ワクチンウイルスおよびワクシニアウイルスベクター | |
| WO2015049633A1 (es) | FORMULACION INMUNOGENICA QUE CONTIENE BCG VIVAS RECOMBINANTES QUE EXPRESAN ANTIGENOS DE METAPNEUMOVIRUS (hMPV), EN UNA SUSPENSION QUE SE PREPARA A PARTIR DE UN LIOFILIZADO SIN LA NECESIDAD DE ADJUVANTE, APTA PARA SU USO FARMACEUTICO. | |
| WO2023236822A1 (zh) | H5n6禽流感广谱性疫苗的开发及其应用 | |
| ES2669018T3 (es) | Procedimiento para la vacunación por vía oral/mucosa por medio de levaduras recombinantes | |
| CN113430178B (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| RU2358981C2 (ru) | Универсальная вакцина против вируса гриппа птиц | |
| CN103316357B (zh) | 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法 | |
| JP2025502236A (ja) | インフルエンザウイルスの弱体化方法および弱体化インフルエンザウイルス株、ならびにその使用 | |
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン |